Ann Marie Navar, MD, PhD; Michael J. Pencina, PhD; Eric D. Peterson, MD, MPH
free access
JAMA Cardiol. 2016;1(8):864-871. doi:10.1001/jamacardio.2016.2861
This study uses NHANES data to assess the representativeness of the findings of SPRINT and the HOPE-3 trial to US patients and to explore the cardiovascular disease risk profiles of various populations with elevated systolic blood pressure.
Ilana B. Richman, MD; Michael Fairley, BE(Hons); Mads Emil Jørgensen, MB; et al.
free access
JAMA Cardiol. 2016;1(8):872-879. doi:10.1001/jamacardio.2016.3517
This cost-effectiveness analysis evaluates the incremental cost-effectiveness of intensive blood pressure management compared with standard management in patients with hypertension.
Adam Castano, MD, MS; Muhammad Haq, MD; David L. Narotsky, MD; et al.
free access
JAMA Cardiol. 2016;1(8):880-889. doi:10.1001/jamacardio.2016.2839
This study describes the diagnostic accuracy of technetium 99m pyrophosphate cardiac imaging for detecting transthyretin cardiac amyloidosis in patient with suspected disease.
Nish Patel, MD; Nileshkumar J. Patel, MD; Conrad J. Macon, MD; et al.
free access
JAMA Cardiol. 2016;1(8):890-899. doi:10.1001/jamacardio.2016.2860
This study uses data from the Nationwide Inpatient Sample to assess the temporal trends, predictors, and outcomes of performing coronary angiography and percutaneous coronary intervention in patients resuscitated after out-of-hospital cardiac arrest with initial rhythms of ventricular tachycardia or pulseless ventricular fibrillation.
Daniel J. Friedman, MD; Craig S. Parzynski, MS; Paul D. Varosy, MD; et al.
open access
JAMA Cardiol. 2016;1(8):900-911. doi:10.1001/jamacardio.2016.2782
This cohort study examines the adoption of subcutaneous implantable cardioverter
defibrillators (ICDs) into clinical practice in the United States, and compares
in-hospital outcomes with those of patients undergoing transvenous ICD
implantation.
Maria Rubini Giménez, MD; Raphael Twerenbold, MD; Jasper Boeddinghaus, MD; et al.
free access
JAMA Cardiol. 2016;1(8):912-920. doi:10.1001/jamacardio.2016.2882
This study (the Advantageous Predictors of Acute Coronary Syndrome Evaluation Study) compares the use of a uniform cutoff level with sex-specific cutoff levels of high-sensitivity coronary troponin T in the diagnosis of acute myocardial infarction.
Riccardo Gherli, MD; Giovanni Mariscalco, MD, PhD; Magnus Dalén, MD; et al.
free access
JAMA Cardiol. 2016;1(8):921-928. doi:10.1001/jamacardio.2016.3028
This multicenter clinical trial evaluates the safety of preoperative use of ticagrelor with or without aspirin in patients with acute coronary syndromes undergoing isolated coronary artery bypass grafting compared with aspirin alone.
Tasneem Khambaty, PhD; Jesse C. Stewart, PhD; Samir K. Gupta, MD; et al.
free access
JAMA Cardiol. 2016;1(8):929-937. doi:10.1001/jamacardio.2016.2716
This cohort study investigates associations between depressive disorders and incident acute myocardial infarction in US veterans with human immunodeficiency virus infection.